Gilad Oren Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$30,343.71
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Gilad Oren

According to the SEC Form 4 filings, Gilad Oren, being in a position of

  1. President/CEO at Aprea Therapeutics, Inc.,
    оver the last 12 months, has bought 28100 shares for $25,009, and sold 0 shares,
    over all time since 2024-03-13, has bought 37500 shares for $55,353, and sold 0 shares.

Biography of Gilad Oren

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $25,0091100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-01-30PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
28,100
0.4492%
$0.89$25,009-5.78%
2025-04-03PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
5,500
0.1023%
$1.84$10,110-17.78%
2024-10-23PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
500
0.0086%
$3.92$1,958-53.33%
2024-10-15PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
250
0.0046%
$2.90$725-39.18%
2024-10-14PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
1,000
0.0163%
$2.59$2,590-27.34%
2024-10-10PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
150
0.0024%
$2.54$381-26.18%
2024-03-13PurchaseAprea Therapeutics, Inc.
APRE
President, CEO
2,000
0.0683%
$7.29$14,580-31.44%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.